The significance of 24-hour monitoring of blood pressure in patients with diabetes mellitus;Die bedeutung der 24-stunden-blutdruckmessung bei patienten mit diabetes mellitus

Deutsche Medizinische Wochenschrift

Volumn 124, Issue 13, 1999, Pages 393-395

  Schernthaner, G ^a,b   Ritz, E ^c   Philipp, Th ^d   Bretzel, R ^e  

^a Rudolfstiftung   (Austria)

^b KRANKENANSTALT RUDOLFSTIFTUNG   (Austria)

^c UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^d UNIVERSITY HOSPITAL ESSEN   (Germany)

^e Med Klin und Poliklin III der U   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD PRESSURE MONITORING; DIABETES MELLITUS; DIABETIC ANGIOPATHY; DIABETIC NEPHROPATHY; HUMAN; HYPERTENSION; PATIENT MONITORING; PROTEINURIA;

EID: 0033118173     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1024323     Document Type: Article

References (19)

1. 1 Chen, J. W., S. L. Jen, W. L. Leo, N. W. Hsu, S. J. Lin, C. T. Ting, M. S. Chang, P. H. Wang: Differential glucose tolerance in dipper and nondipper essential hypertension. Diabet. Care 21 (1998) 1743-1748.
2. 2 Equiluz-Bruck, S., C. Schnack, H. P. Kopp u. G. Schernthaner: Non-dipping of nocturnal blood pressure is related tourinary albumin excretion rate in patients with type-2-diabetes mellitus. Amer. J. Hypertens. 9 (1996) 1139-1143.
3. 3 Fagerudd, J. A., I. Tarnow, P. Jacobsen, S. Stenman, F. S. Nielsen, K. J. Pettersson-Fernholm, C. Grönhagen-Risky, H. H. Parving, P. I. J. Groop: Predisposition to essential hypertension and development of diabetic nephropathy in IDDM patients. Diabetes 47 (1998) 439-444.
4. 4 Hansson, L., A. Zanchetti, S. G. Carruthers, B. Dahlöf, D. Elmfeldt, S. T. Julius, J. Menrad, K. H. Rahn, H. Wedel, H. Westerling for the HOT Study Group: Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the hypertension optimal treatment (HOT) randomised trial. Lancet 351 (1998) 1755-1762.
5. 5 ISIS-2 (Second International Study of infarct Survival) Collaborative Group: Morning peak in the incidence of myocardial infarction experience in the ISIS-2 trial. Europ. Heart J. 13 (1992) 594-598.
6. 6 Nakano, S., M. Fukuda, F. Hotta, T. Ito, T. Ishii, M. Kitazawa, M. Nishizawa, T. Kigoshi, K. Uchicla: Reversed circadian blood pressure rhythm is associated with occurrences of both fatal and nonfatal vascular events in NIDDM subjects. Diabetes 47 (1998) 1501-1506.
7. 7 Nielsen, F. S., P. Gaede, P. Vedel, O. B. Pedersen, H. H. Parving: White coat hypertension in NIDDM patients with and without incipient and overt diabetic nephropathy. Diabet, Care 20 (1997) 859-863.
8. 8 Nielsen, F. S., P. Rossing, L. E. Bang, T. L. Svendsen, M. A. Gall, U. M. Smidt, H. H. Parving: On the mechanismus of blunted nocturnal decline in arterial blood pressure in NIDDM patients with diabetic nephropathy. Diabetes 44 (1995) 783-789.
9. 9 Pickering, T., G. James, C. Boddie et al. How common is white coat hypertension? JAMA 259 (1988), 225-228.
10. 10 Poulsen, P. L., T. Beck, E. Ebbehoj, K. W. Hansen, C. E. Mogensen: 24-h ambulatory blood pressure and retinopathy in normoalbuminuric IDDM patient. Diabetologia 41 (1998), 105-110.
11. 11 Poulsen, P. L., E. Ebbehoi, K. W. Hansen, C. E. Mogensen: 24-hour pressure and autonomic function is related to albumin excretion within the normoalbuminuric range in IDDM patients. Diabetologia 40 (1997), 718-725.
12. 12 Poulsen, P. L., K. W. Hansen, C. E. Mogensen: Ambulatory blood pressure in the transition from normo-to microalbuminuria. A longitudinal study in IDDM patients. Diabetes 43 (1994), 1248-1253.
13. 13 Schernthaner, G.: Arterielle Hypertonie und Diabetes mellitus. Teil 1: Interventionsstrategien zur kardiovaskulären Protektion. Diabet. u. Stoffw. 5 (1996), 223-232.
14. 14 Schnack, C. H., W. Scheithauer, C. H. Gisinger, J. Winkler, G. Schernthaner: Prevalence of microalbuminuria in maturity onset primarily non-insulin requiring diabetes mellitus: effect of disease duration, glycemic control and mean systemic blood pressure. J. diabet. Complic. 1 (1987), 132-136.
15. 15 SHEP Cooperative Research Group: Prevention of stroke by antihypertensive drug treatment in older person with isolated systolic hypertension: final results of the Systolic Hypertension the Elderly Program (SHEP). J. Amer. med. Ass. 265 (1991), 3255-3264.
16. 16 Sturrock, N. D., N. Pound, G. M. Peck, C. M. Soar, W. J. Jeffcoate: An assessment of blood pressure measurement in a diabetic clinic using random-zero, semi-automated, and 24-hour monitoring. Diabet. Med. 14 (1997), 370-375.
17. 17 The National High Blood Pressure Education Program Working Group: National High Blood Pressure Education Program Working Group report on hypertension in diabetes. Hypertension 23 (1994), 145-158.
18. 18 UK Prospective Diabetes Study (UKPDS) Group: Tight blood pressure control and risk of macrovascular and microvascular complication in type-2 diabetes. UKPDS 38 Brit. med. J. 317 (1998), 703-713.
19. 19 UK Prospective Diabetes Study (UKPDS) Group: Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type-2 diabetes: UKPDS 39. Brit. med. J. 317 (1998), 713-719.